Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.
暂无分享,去创建一个
Sheng Qi | P. Tipduangta | S. Qi | William J McAuley | Ziyi Yang | W. McAuley | Ziyi Yang | Pratchaya Tipduangta
[1] C. Branford-White,et al. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. , 2010, International journal of pharmaceutics.
[2] Zhiping Zhang,et al. The applications of Vitamin E TPGS in drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[4] E. Munson,et al. Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy. , 2014, Molecular pharmaceutics.
[5] A. Chow,et al. Production and characterization of a spray-dried hydroxypropyl-β-cyclodextrin/quercetin complex , 2009, Drug development and industrial pharmacy.
[6] Bruno C. Hancock,et al. Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.
[7] R. Suryanarayanan,et al. Molecular mobility as an effective predictor of the physical stability of amorphous trehalose. , 2012, Molecular pharmaceutics.
[8] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] M. Lauer,et al. Rapid Assessment of Homogeneity and Stability of Amorphous Solid Dispersions by Atomic Force Microscopy—From Bench to Batch , 2013, Pharmaceutical Research.
[10] Michael J. Pikal,et al. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry. , 2002, Journal of pharmaceutical sciences.
[11] Mark E. Davis,et al. Studies on mesoporous materials II. Synthesis mechanism of MCM-41 , 1993 .
[12] F. Vogt,et al. Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements. , 2010, Molecular pharmaceutics.
[13] J. S. Beck,et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.
[14] R. Bogner,et al. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates. , 2011, Journal of pharmaceutical sciences.
[15] Michael J. Pikal,et al. Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals , 2010, Pharmaceutical Research.
[16] George Zografi,et al. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state , 1990 .
[17] Deliang Zhou,et al. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. , 2002, Journal of pharmaceutical sciences.
[18] Gareth R. Williams,et al. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies. , 2014, Journal of pharmaceutical sciences.
[19] D. Craig. A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behaviour of polyethylene glycols , 1995 .
[21] Michael J. Pikal,et al. Emerging Freeze-Drying Process Development and Scale-up Issues , 2011, AAPS PharmSciTech.
[22] Y. Yoshihashi,et al. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. , 2012, International journal of pharmaceutics.
[23] Aditya Mohan Kaushal,et al. Molecular and thermodynamic aspects of solubility advantage from solid dispersions. , 2007, Molecular pharmaceutics.
[24] S. Yoshioka,et al. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. , 2007, Journal of pharmaceutical sciences.
[25] Han‐Gon Choi,et al. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407 , 2008, Archives of pharmacal research.
[26] K. Sekiguchi,et al. STUDIES ON ABSORPTION OF EUTECTIC MIXTURE. II. ABSORPTION OF FUSED CONGLOMERATES OF CHLORAMPHENICOL AND UREA IN RABBITS. , 1964, Chemical & pharmaceutical bulletin.
[27] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[28] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[29] Bradley F. Chmelka,et al. Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures , 1998 .
[30] Gareth R. Williams,et al. Electrospun nanofibers in drug delivery: recent developments and perspectives. , 2012, Therapeutic delivery.
[31] Amrit Paudel,et al. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone). , 2010, Molecular pharmaceutics.
[32] J. Rantanen,et al. Characterisation of blends of paracetamol and citric acid , 2007, The Journal of pharmacy and pharmacology.
[33] Jean-Marie Devoisselle,et al. Solid-State NMR Study of Ibuprofen Confined in MCM-41 Material , 2006 .
[34] D. Craig,et al. The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.
[35] M. B. James,et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. , 2007, International journal of pharmaceutics.
[36] Jing Wang,et al. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. , 2011, Journal of colloid and interface science.
[37] Y. K. Choi,et al. Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique. , 2012, International journal of pharmaceutics.
[38] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[39] Madalena Dionísio,et al. Amorphous Ibuprofen Confined in Nanostructured Silica Materials: A Dynamical Approach , 2011 .
[40] H. Santos,et al. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. , 2011, International journal of pharmaceutics.
[41] S. Qi,et al. An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres. , 2010, Journal of pharmaceutical sciences.
[42] Feng Qian,et al. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.
[43] Lian Yu,et al. Solubility of Small-Molecule Crystals in Polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA , 2009, Pharmaceutical Research.
[44] Pablo G. Debenedetti,et al. Supercooled liquids and the glass transition , 2001, Nature.
[45] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.
[46] L. S. Taylor,et al. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. , 2010, Molecular pharmaceutics.
[47] M. Harris,et al. Evaluation of the microstructure of semicrystalline solid dispersions. , 2010, Molecular pharmaceutics.
[48] Patrick Augustijns,et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[49] Sung-Joo Hwang,et al. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] G. Verreck,et al. Preparation and Characterization of Nanofibers Containing Amorphous Drug Dispersions Generated by Electrostatic Spinning , 2003, Pharmaceutical Research.
[51] A. Healy,et al. Amorphous Solid Dispersions of Sulfonamide/Soluplus® and Sulfonamide/PVP Prepared by Ball Milling , 2013, AAPS PharmSciTech.
[52] M. Espina,et al. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery , 2012, International journal of nanomedicine.
[53] Hsin-Yun Hsu,et al. Effect of substrates on naproxen-polyvinylpyrrolidone solid dispersions formed via the drop printing technique. , 2013, Journal of pharmaceutical sciences.
[54] S. Qi,et al. Microstructure of an immiscible polymer blend and its stabilization effect on amorphous solid dispersions. , 2013, Molecular pharmaceutics.
[55] M Ikeda,et al. Stability of amorphous indomethacin compounded with silica. , 2001, International journal of pharmaceutics.
[56] Thorsteinn Loftsson,et al. Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.
[57] J. Rantanen,et al. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[58] Thorsteinn Loftsson,et al. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. , 2012, Journal of pharmaceutical sciences.
[59] M. Brewster,et al. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes , 2011, The Journal of pharmacy and pharmacology.
[60] Sejal Shah,et al. Melt extrusion with poorly soluble drugs. , 2013, International journal of pharmaceutics.
[61] Karthik Nagapudi,et al. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and Neusilin. , 2011, Journal of pharmaceutical sciences.
[62] Niklas Sandler,et al. Printing technologies in fabrication of drug delivery systems , 2013, Expert opinion on drug delivery.
[63] F. Vogt,et al. A Solid-State NMR Study of Amorphous Ezetimibe Dispersions in Mesoporous Silica , 2013, Pharmaceutical Research.
[64] V. Caron,et al. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. , 2011, Molecular pharmaceutics.
[65] Hsin-Yun Hsu,et al. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions. , 2013, The journal of physical chemistry. B.
[66] Andrea Gazzaniga,et al. Injection Molding and its application to drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[67] Peter Kleinebudde,et al. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion. , 2012, International journal of pharmaceutics.
[68] Patrick Augustijns,et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.
[69] S. Ohtake,et al. Effect of water on the chemical stability of amorphous pharmaceuticals: I. Small molecules. , 2013, Journal of pharmaceutical sciences.
[70] C. Roberts,et al. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5. , 2008, Journal of pharmaceutical sciences.
[71] Amrit Paudel,et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. , 2013, International journal of pharmaceutics.
[72] Ashwini Nangia,et al. Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals , 2011 .
[73] G. Verreck,et al. Supersaturating drug delivery systems: effect of hydrophilic cyclodextrins and other excipients on the formation and stabilization of supersaturated drug solutions. , 2008, Die Pharmazie.
[74] Ping I. Lee,et al. Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation. , 2013, Molecular pharmaceutics.
[75] M. Khan,et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.
[76] S. Majumdar,et al. Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology , 2012, AAPS PharmSciTech.
[77] J. Moffat,et al. Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe-based thermal and spectroscopic nanocharacterization methods. , 2013, Molecular pharmaceutics.
[78] V. Caron,et al. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.
[79] Li-Min Wang,et al. An electrospray technique for hyperquenched glass calorimetry studies: Propylene glycol and di-n-butyl phthalate , 2007 .
[80] Sheng Qi,et al. Characterisation and Prediction of Phase Separation in Hot-Melt Extruded Solid Dispersions: A Thermal, Microscopic and NMR Relaxometry Study , 2010, Pharmaceutical Research.
[81] Fredrickson,et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.
[82] Yun Hu,et al. Mechanochemical Reaction of Sulfathiazole with Carboxylic Acids: Formation of a Cocrystal, a Salt, and Coamorphous Solids , 2014 .
[83] Jan Van Humbeeck,et al. Influence of Preparation Methods on Solid State Supersaturation of Amorphous Solid Dispersions: A Case Study with Itraconazole and Eudragit E100 , 2010, Pharmaceutical Research.
[84] T. Konno,et al. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. I. Effect of vapor pressure of the medicinals on changes in crystalline properties. , 1986, Chemical & pharmaceutical bulletin.
[85] M D Ediger,et al. Spatially heterogeneous dynamics in supercooled liquids. , 2003, Annual review of physical chemistry.
[86] L. Carpentier,et al. Solid-state vitrification of crystalline griseofulvin by mechanical milling. , 2012, Journal of pharmaceutical sciences.
[87] H. Santos,et al. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles. , 2011, International journal of pharmaceutics.
[88] K. Grzybowska,et al. Molecular dynamics, physical stability and solubility advantage from amorphous indapamide drug. , 2013, Molecular pharmaceutics.
[89] Vesa-Pekka Lehto,et al. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. , 2010, Molecular pharmaceutics.
[90] H. Gotoh,et al. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[91] Colin E. Rowlings,et al. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability , 1995 .
[92] Charles E. Martin,et al. Pharmaceutical Applications of Hot-Melt Extrusion: Part I , 2007, Drug development and industrial pharmacy.
[93] R. Tan,et al. Dissolution enhancement of indomethacin via amorphization using co-milling and supercritical co-precipitation processing , 2013 .
[94] Michael Lee Branham,et al. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[95] S. Bates,et al. Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns , 2006, Pharmaceutical Research.
[96] P York,et al. Comminution of ibuprofen to produce nano-particles for rapid dissolution. , 2011, International journal of pharmaceutics.
[97] Michael J Pikal,et al. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state. , 2005, Journal of pharmaceutical sciences.
[98] C. Strachan,et al. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. , 2011, Molecular pharmaceutics.
[99] Rainer H Müller,et al. Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.
[100] Niklas Sandler,et al. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[101] Jennifer B Dressman,et al. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[102] T. Rades,et al. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[103] H. Gotoh,et al. Physicochemical properties of amorphous salt of cimetidine and diflunisal system. , 2002, International journal of pharmaceutics.
[104] S. Riegelman,et al. Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.
[105] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[106] Deepak Bahl,et al. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: Amorphization Kinetics, Physical Stability and Mechanism , 2006, Pharmaceutical Research.
[107] J. B. Higgins,et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .
[108] J. Moffat,et al. Spatial Characterization of Hot Melt Extruded Dispersion Systems Using Thermal Atomic Force Microscopy Methods: The Effects of Processing Parameters on Phase Separation , 2014, Pharmaceutical Research.
[109] Thomas Rades,et al. Emerging trends in the stabilization of amorphous drugs. , 2013, International journal of pharmaceutics.
[110] Qinfu Zhao,et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica , 2013, International journal of nanomedicine.
[111] G. Zografi,et al. Effects of Lyophilization on the Physical Characteristics and Chemical Stability of Amorphous Quinapril Hydrochloride , 2000, Pharmaceutical Research.
[112] F. Hirayama,et al. Inhibitory Effect of 2‐Hydroxypropyl‐β‐cyclodextrin on Crystal‐growth of Nifedipine During Storage: Superior Dissolution and Oral Bioavailability Compared with Polyvinylpyrrolidone K‐30 , 1992, The Journal of pharmacy and pharmacology.
[113] Elaine Merisko-Liversidge,et al. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.
[114] Sheng Qi,et al. Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: etravirine. , 2011, Journal of pharmaceutical sciences.
[115] C. Prestidge,et al. Silica materials in drug delivery applications. , 2011, Current drug discovery technologies.
[116] J. Mitchell,et al. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers , 2013, Drug development and industrial pharmacy.
[117] C. Jackson,et al. Vitrification and Crystallization of Organic Liquids Confined to Nanoscale Pores , 1996 .
[118] Bruno C. Hancock,et al. Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.
[119] J. Martens,et al. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs. , 2011, Therapeutic delivery.
[120] Duk Soon Choi,et al. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. , 2008, International journal of pharmaceutics.
[121] P. Belton,et al. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature. , 2010, Journal of pharmaceutical sciences.
[122] Niels Bent Larsen,et al. Studies of spin-coated polymer films , 2005 .
[123] Lynne S. Taylor,et al. Ability of Different Polymers to Inhibit the Crystallization of Amorphous Felodipine in the Presence of Moisture , 2008, Pharmaceutical Research.
[124] M. Lawrence,et al. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions. , 2013, International journal of pharmaceutics.
[125] L Yu,et al. Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.
[126] Jin Kim,et al. Physicochemical characterization of solid dispersion of furosemide with TPGS. , 2003, International journal of pharmaceutics.
[127] P York,et al. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. , 2007, Advanced drug delivery reviews.
[128] N. Rodríguez-Hornedo,et al. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. , 2007, Journal of pharmaceutical sciences.
[129] George Zografi,et al. Assessing the performance of amorphous solid dispersions. , 2012, Journal of pharmaceutical sciences.
[130] R. Bogner,et al. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. , 2012, Journal of pharmaceutical sciences.
[131] Cheng-Hung Hsu,et al. Solid-state transformation of different gabapentin polymorphs upon milling and co-milling. , 2010, International journal of pharmaceutics.
[132] K. Peh,et al. Effect of HPMC concentration on β-cyclodextrin solubilization of norfloxacin. , 2014, Carbohydrate polymers.
[133] He Hui,et al. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. , 2010, Molecular pharmaceutics.
[134] Jérôme Mantanus,et al. PAT tools for the control of co-extrusion implants manufacturing process. , 2013, International journal of pharmaceutics.
[135] J. Humbeeck,et al. Evaluation of the formulation of solid dispersions by co-spray drying itraconazole with Inutec SP1, a polymeric surfactant, in combination with PVPVA 64. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[136] R. Bogner,et al. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization. , 2011, Journal of pharmaceutical sciences.
[137] Christel A.S. Bergström,et al. Early drug development predictions of glass-forming ability and physical stability of drugs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[138] J. Rantanen,et al. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[139] Patrick J. Marsac,et al. Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility , 2006, Pharmaceutical Research.
[140] Keiji. Yamamoto,et al. Dissolution improvement of RS-8359 by the solid dispersion prepared by the solvent method , 1998 .
[141] J. Devoisselle,et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[142] Paul F. McMillan,et al. Relaxation in glassforming liquids and amorphous solids , 2000 .
[143] C. Angell. Relaxation in liquids, polymers and plastic crystals — strong/fragile patterns and problems☆ , 1991 .
[144] T. Azaïs,et al. Solution State NMR Techniques Applied to Solid State Samples: Characterization of Benzoic Acid Confined in MCM-41 , 2010 .
[145] Yasuhiro Sakamoto,et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials , 2000, Nature.
[146] A. Saha,et al. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[147] Huibi Xu,et al. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[148] C Vervaet,et al. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. , 2011, International journal of pharmaceutics.
[149] T. De Beer,et al. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[150] Joel Rosenblatt,et al. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[151] K. Terada,et al. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy. , 2011, International journal of pharmaceutics.
[152] Patrick J. Marsac,et al. Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters , 2008, Pharmaceutical Research.
[153] Chandan Bhugra,et al. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. , 2008, Journal of pharmaceutical sciences.
[154] J. Dressman,et al. In vitro tools for evaluating novel dosage forms of poorly soluble, weakly basic drugs: case example ketoconazole. , 2013, Journal of pharmaceutical sciences.
[155] Bruno C. Hancock,et al. Interpretation of relaxation time constants for amorphous pharmaceutical systems. , 2000, Journal of pharmaceutical sciences.
[156] K. Leong,et al. Electrohydrodynamics: A facile technique to fabricate drug delivery systems. , 2009, Advanced drug delivery reviews.
[157] O. Corrigan. Mechanisms of Dissolution of Fast Release Solid Dispersions , 1985 .
[158] S. Onoue,et al. Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[159] Michael T Harris,et al. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions. , 2012, Molecular pharmaceutics.
[160] S. Riegelman,et al. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. , 1969, Journal of pharmaceutical sciences.
[161] P. Belton,et al. Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. , 2008, International journal of pharmaceutics.
[162] John Baldoni,et al. Electrospun Nanofibers in Oral Drug Delivery , 2010, Pharmaceutical Research.
[163] Patrick Augustijns,et al. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[164] L. Naesens,et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[165] Deliang Zhou,et al. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin. , 2008, Molecular pharmaceutics.
[166] Jianxiang Zhang,et al. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. , 2013, Advanced drug delivery reviews.
[167] B. Wunderlich. A classification of molecules, phases, and transitions as recognized by thermal analysis , 1999 .
[168] V. Lehto,et al. Mesoporous systems for poorly soluble drugs. , 2013, International journal of pharmaceutics.
[169] T. De Beer,et al. In-line NIR spectroscopy for the understanding of polymer-drug interaction during pharmaceutical hot-melt extrusion. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[170] G. Alderborn,et al. Moisture-induced surface crystallization of spray-dried amorphous lactose particles studied by atomic force microscopy. , 2004, Journal of pharmaceutical sciences.
[171] C. Strachan,et al. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[172] W. Ali,et al. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. , 2010, International journal of pharmaceutics.
[173] R. Suryanarayanan,et al. Local mobility in amorphous pharmaceuticals--characterization and implications on stability. , 2009, Journal of pharmaceutical sciences.
[174] Charles E. Martin,et al. Pharmaceutical Applications of Hot-Melt Extrusion: Part II , 2007, Drug development and industrial pharmacy.
[175] Thomas Rades,et al. Correlating thermodynamic and kinetic parameters with amorphous stability. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[176] G. Zografi,et al. Phase Behavior of Binary and Ternary Amorphous Mixtures Containing Indomethacin, Citric Acid, and PVP , 1998, Pharmaceutical Research.
[177] M. Descamps,et al. Solid State Amorphization of Pharmaceuticals , 2009 .
[178] M. Descamps,et al. Low- and high-frequency Raman investigations on caffeine: polymorphism, disorder and phase transformation. , 2011, The journal of physical chemistry. B.
[179] Bernard Van Eerdenbrugh,et al. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. , 2010, Journal of pharmaceutical sciences.
[180] S. Qi,et al. Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[181] Simon Bates,et al. Evaluation of Drug-Polymer Miscibility in Amorphous Solid Dispersion Systems , 2009, Pharmaceutical Research.
[182] R. Suryanarayanan,et al. Correlation between molecular mobility and physical stability of amorphous itraconazole. , 2013, Molecular pharmaceutics.
[183] Bernard Van Eerdenbrugh,et al. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts. , 2010, Journal of pharmaceutical sciences.
[184] T. Rades,et al. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[185] R. Tan,et al. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. , 2011, International journal of pharmaceutics.
[186] M. Descamps,et al. A new protocol to determine the solubility of drugs into polymer matrixes. , 2013, Molecular pharmaceutics.
[187] B. Sarmento,et al. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. , 2007, Drug discovery today.
[188] T. Rades,et al. Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation. , 2002, International journal of pharmaceutics.
[189] C. Jackson,et al. The melting behavior of organic materials confined in porous solids , 1990 .
[190] Shigeo Kojima,et al. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. , 2004, Journal of pharmaceutical sciences.
[191] K. Motoyama,et al. Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes , 2011 .
[192] Shun-Ji Jin,et al. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. , 2008, International journal of pharmaceutics.